Asthma

What is Asthma?

Asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to difficulty breathing. It can range from mild to severe and often requires long-term management.

Types of Asthma

1. Allergic Asthma

• Triggered by allergens such as pollen, dust mites, or pet dander.
• Common symptoms include: Wheezing, coughing, and shortness of breath.

2. Non-Allergic Asthma

• Triggered by factors other than allergens, such as stress, exercise, cold air, or smoke.
• Less common than allergic asthma.

3. Exercise-Induced Asthma

• Occurs during or after physical activity.
• Symptoms: Shortness of breath, chest tightness, and coughing.

4. Occupational Asthma

• Caused by workplace irritants such as chemical fumes, gases, or dust.
• Can affect adults who are exposed to specific work environments.

Common Symptoms of Asthma

• Wheezing: A whistling sound when breathing.
• Shortness of breath
• Chest tightness or pain
• Coughing, especially at night or early in the morning.
• Difficulty breathing that may worsen with activity.

Risk Factors

• Family history: Increased risk if parents have asthma.
• Allergies: Having other allergic conditions, such as hay fever.
• Respiratory infections: Frequent infections in early childhood.
• Exposure to irritants: Such as tobacco smoke, pollution, or workplace chemicals.
• Obesity: Associated with a higher risk of asthma.

Prevention and Management Strategies

• Avoid known triggers: Identify and minimize exposure to allergens and irritants.
• Maintain a healthy lifestyle: Regular exercise and a balanced diet can help improve lung function.
• Follow an asthma action plan: Work with a healthcare provider to create a personalized plan.
• Monitor breathing: Use peak flow meters to track asthma control.
• Stay up-to-date with vaccinations: Reduce the risk of respiratory infections.

Treatment Options

• Quick-relief (rescue) medications: Used during an asthma attack to relax airway muscles.
  • Examples: Short-acting beta-agonists (e.g., albuterol).
• Long-term control medications: Taken daily to prevent symptoms and manage chronic asthma.
  • Examples: Inhaled corticosteroids, long-acting beta-agonists, leukotriene modifiers.
• Biologic therapies: For severe asthma cases, targeted treatments that block specific immune system pathways.
• Allergy treatments: Such as immunotherapy, if asthma is triggered by allergens.

Complications of Asthma

• Severe asthma attacks: Can be life-threatening and require emergency treatment.
• Frequent hospital visits: Resulting from uncontrolled symptoms.
• Permanent airway changes: Ongoing inflammation may lead to structural changes in the airways.
• Reduced quality of life: Can limit daily activities and participation in physical activities.
• Emotional and mental health challenges: Anxiety and stress related to chronic condition management.

References & Research

Historical Background

Asthma has been recognized since ancient times, with the term coined by Hippocrates around 450 BCE. Henry Hyde Salter provided one of the first modern clinical descriptions of asthma in his 1860 work On Asthma: Its Pathology and Treatment, establishing it as a distinct disease of airway spasm rather than a symptom of other conditions.

Key Research Papers

1. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783-800.
2. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Eur Respir J. 2020;56(2):2000588.
3. Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350-400.
4. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716-725.
5. Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005-1015.
6. Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378(26):2486-2496.
7. Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198-1207.
8. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial (START). Lancet. 2003;361(9363):1071-1076.
9. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma (TALC). N Engl J Med. 2010;363(18):1715-1726.
10. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31(1):143-178.
11. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999;340(3):197-206.
12. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144(12):904-912.

Back to Table of Contents